Affordable Access

Access to the full text

SLC12A8 plays a key role in bladder cancer progression and EMT

Authors
  • Li, Shun-Lai1
  • Li, Zheng-Feng1
  • Cao, Qing-Wei2
  • Wang, Wen-Zhen1
  • 1 The Fifth People’s Hospital of Jinan, Department of Urology, No. 24297, Jingshi Road, Huaiyin District, Shandong , (China)
  • 2 Shandong Provincial Hospital, Department of Urology, No. 9677, Jingshi Road, Lixia District, Shandon , (China)
Type
Published Article
Journal
Open Medicine
Publisher
De Gruyter
Publication Date
Dec 08, 2020
Volume
15
Issue
1
Pages
58–67
Identifiers
DOI: 10.1515/med-2021-0013
Source
De Gruyter
Keywords
License
Green

Abstract

Bladder cancer is the most common malignant tumor of the urinary system. The intention of the present research is to explore the prognostic value and biological function of solute carrier family 12 member 8 (SLC12A8) in bladder cancer. The analysis based on the TCGA and ONCOMINE database revealed that the expression of SLC12A8 in bladder cancer was notably increased compared with the normal group. SLC12A8 expression was notably correlated with the age, pathological stage, T-stage, and lymph node metastasis of bladder cancer patients. Moreover, the patients’ overall survival was notably shorter in the high SLC12A8 group. Compared with the control, SLC12A8 upregulation enhanced the proliferative, invasive, and migratory capacities of bladder cancer cells and promoted the expression of epithelial–mesenchymal transition (EMT) protein markers including β-catenin, vimentin, snail, and slug, while reduced the expression of E-cadherin. In the case of downregulated SLC12A8 expression, the proliferative, invasive, and migratory capacities of bladder cancer cells and the expression of EMT protein markers presented the opposite trend. This study demonstrated that SLC12A8 was highly correlated with oncogenesis and progression of bladder cancer, indicating that SLC12A8 may be a meaningful biomarker for initial diagnosis and early treatment of bladder cancer.

Report this publication

Statistics

Seen <100 times